News & Events
- Home
- News & Events
-
AMP 2024, British Columbia, Canada
2024-07-03The AMP 2024 Annual Meeting & Expo is the only educational event developed and presented by internationally renowned molecular diagnostic professionals.
-
MEDICA 2024, Dusseldorf, Germany
2024-07-01MEDICA is the world’s largest event for the medical sector. For more than 40 years it has been firmly established on every expert’s calendar. There are many reasons why MEDICA is so unique.
-
ADLM 2024, CHICAGO IL, USA (7/30-8/1)
2024-03-28The Association for Diagnostics & Laboratory Medicine (formerly AACC) is a global scientific and medical professional organization dedicated to clinical laboratory science and its application to healthcare.
-
BiOptic Qampmini Thermal Cycler has received Class I Medical Device Certification!
2023-12-21BiOptic Qampmini Thermal Cycler has received Class I Medical Device Certification of Taiwan Food and Drug Administration (TFDA)
Qampmini has been listed as a Class I Medical Device in the U.S. Food and Drug Administration (FDA) since JAN 2023, and is now granted by the Taiwan Food and Drug Administration (TFDA). It can be sold as a medical device to demand institutions from the date of grant. -
【Congratulations!】BiOptic has received an India invention patent
2023-12-18BiOptic has received a new invention patent for the Qsep400 Bio-Fragment Analyzer and 4-channel cartridge from India!The biopharmaceutical industry in India is a very important emerging market in the globe. Local R&D investment in the biopharmaceutical industry accounts for 60% of the total investment. Plus, it has become the world's largest vaccine producer and the world's largest manufacturer of generic drugs!
-
Algorithm for optimized mRNA design improves stability and immunogenicity
2023-12-14Messenger RNA (mRNA) vaccines are being used to combat the spread of COVID-19(refs. 1–3), but they still exhibit critical limitations caused by mRNA instability and degradation, which are major obstacles for the storage, distribution and efficacy of the vaccine products4. Increasing secondary structure lengthens mRNA half-life, which, together with optimal codons, improves protein expression5.